Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina-Reference-Cited by-同舟云学术

Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina

Published:2022-04-21 Issue:8 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Villanueva Gabriela¹^ORCID,Sampor Claudia¹,Moreno Florencia²,Alderete Daniel¹,Moresco Angelica³^ORCID,Pinto Natalia⁴,Szijan Irene⁵⁶,Schaiquevich Paula⁶^ORCID,Felice María Sara¹,Rose Adriana¹,Zubizarreta Pedro¹,Sgroi Mariana⁷,Fandiño Adriana⁷,Chantada Guillermo¹⁶^ORCID

Affiliation:

1. Hematology and Oncology Department Hospital JP Garrahan Buenos Aires Argentina

2. Instituto Nacional del Cáncer Registro Onco‐pediatrico Hospitalario Argentino (ROHA) Buenos Aires Argentina

3. Department of Genetics Hospital JP Garrahan Buenos Aires Argentina

4. Department of Radiotherapy Hospital JP Garrahan Buenos Aires Argentina

5. Cátedra de Genética, Facultad de Farmacia y Bioquímica, Hospital de Clínicas University of Buenos Aires Buenos Aires Argentina

6. National Scientific and Technical Research Council (CONICET) Buenos Aires Argentina

7. Ophthalmology Department Hospital JP Garrahan Buenos Aires Argentina

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29710

Reference38 articles.

1. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center

2. Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up

3. Patterns of Cause-Specific Mortality Among 2053 Survivors of Retinoblastoma, 1914–2016

4. Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma

5. Risk of Subsequent Malignant Neoplasms in Long-Term Hereditary Retinoblastoma Survivors After Chemotherapy and Radiotherapy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What have we learnt about intraarterial chemotherapy (Ophthalmic Artery Chemosurgery) for retinoblastoma in the past 18 years? The third A. Linn Murphree Lecture;Ophthalmic Genetics;2024-09-04

2. Impact of childhood/adolescent cancer history on prognosis in parotid mucoepidermoid carcinoma;British Journal of Oral and Maxillofacial Surgery;2024-09

3. Overall survival and cause‐specific mortality in a hospital‐based cohort of retinoblastoma patients in São Paulo, Brazil;International Journal of Cancer;2024-08-13

4. Utility of carboplatin therapeutic drug monitoring for the treatment of neonate and infant retinoblastoma patients in the United Kingdom;British Journal of Cancer;2024-06-13

5. Incidence of second primary cancers in patients with retinoblastoma: a systematic review and meta-analysis;Frontiers in Oncology;2024-03-28